Evidence map›Paper›PMID 37719971›Full record

ArticleFrontiers in cardiovascular medicine2023

Clinical presentation and neurovascular manifestations of cardiac myxomas and papillary fibroelastomas: a retrospective single-institution cohort study.

Akshay Mathavan, Akash Mathavan, Urszula Krekora, Mohit Mathavan, Vanessa Rodriguez, Ellery Altshuler, Brianna Nguyen, Mohammed Ruzieh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Akshay Mathavan *Department of Internal Medicine, University of Florida, Gainesville, FL, United States.
Akash Mathavan *Department of Internal Medicine, University of Florida, Gainesville, FL, United States.
Urszula KrekoraUniversity of Central Florida College of Medicine, University of Central Florida, Orlando, FL, United States.
Mohit MathavanDepartment of Family Medicine, Ocala Hospital, Ocala, FL, United States.
Vanessa RodriguezDepartment of Internal Medicine, University of South Florida, Tampa, FL, United States.
Ellery AltshulerDepartment of Internal Medicine, University of Florida, Gainesville, FL, United States.
Brianna NguyenUniversity of Florida College of Medicine, University of Florida, Gainesville, FL, United States.
Mohammed RuziehDivision of Cardiovascular Medicine, University of Florida, Gainesville, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Primary cardiac tumors are often benign and commonly present as cardiac myxomas (CMs) or papillary fibroelastomas (CPFEs). There is a paucity of prognostic indicators for tumor burden or potential for embolic cerebrovascular events (CVEs). This study was performed to address these gaps. Methods: Medical records at the University of Florida Health Shands Hospital between 1996 and 2021 were screened to identify patients with CMs or CPFEs. Clinical features, echocardiographic reports, and CVE outcomes were quantitatively assessed. Results: A total of 55 patients were included in the study: 28 CM (50.9%) and 27 CPFE (49.1%) patients. Baseline patient characteristics were similar among patients. The neutrophil-lymphocyte ratio was correlated ( Conclusion: The neutrophil-lymphocyte ratio may prognosticate tumor size and recurrence of neurologic events. An increased risk of CVE within 5 years of mass resection is almost exclusive to patients initially presenting with CVEs.

Indexed as

benign cardiac neoplasmscardiac myxomascardiac papillary fibroelastomacerebrovascular eventsneutrophil–lymphocyte (N/L ratio)

Identifiers

PMID37719971
PMCPMC10503431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.